F20 F25
Conditions
Interventions
Group 1: benperidole
Evaluation of retrospective analysis of efficacy, side effects and acceptance of treated persons
Group 2: intramuscular aripiprazole
Evaluation of retrospective analysis of effica
Sponsors
LVR-Klinik Köln
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: diagnosis (ICD10) of schizophrenia (F20) or schizoaffective disorder (F25) BPRS of at least 12 points age of 18 up to 65 years written informed consent on participation to the study
Exclusion criteria
Exclusion criteria: Patients which do not fullfill the criteria (ICD10) for schizophrenia or schizoaffective disorder. Age under 18 or over 65 years. A BPRS of lower then 12 points.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change of BPRS at first and at last administration of parenteral treatment 2. Change of positive and negative syndrome scale - excited component at first and at last administration of parenteral treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. total number of parenteral injections 2. duration of parenteral incejtions in days 3. duration of treatment in hospital after last parenteral injection 4. dose of sedatives given to patients in chlorpromazin equivalents 5. side effects and acceptance rated by UKU Rating Scale 6. acceptance of patients the day after the last injection by visual analog scale | — |
Countries
Germany
Contacts
Public ContactDirk Reske
LVR-Klinik Köln
Outcome results
None listed